김휘영(金輝瑛) 부교수

의학과

김휘영 프로필 사진

				
연구실적
  • Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B CANCERS, 2021, v.13 no.14, 3424
    SCIE Scopus dColl.
  • Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression Journal of Pathology, 2021, v.253 no.1, 55-67
    SCIE Scopus dColl.
  • Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study Digestive Diseases and Sciences, 2021, v.66 no.7, 2427-2438
    SCIE Scopus dColl.
  • Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL, 2021 , 12-20
    SCIE Scopus KCI dColl.
  • Recent advances in nonalcoholic fatty liver disease metabolomics CLINICAL AND MOLECULAR HEPATOLOGY, 2021, v.27 no.4, 553-559
    SCIE Scopus KCI dColl.
  • Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis CLINICAL AND MOLECULAR HEPATOLOGY, 2021, v.27 no.4, 535-552
    SCIE Scopus KCI dColl.
  • A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function BMC CANCER, 2020, v.20 no.1, 504
    SCIE Scopus dColl.
  • Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study GUT, 2020, v.69 no.12, 2214-2222
    SCIE Scopus dColl.
  • Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease BMC NEPHROLOGY, 2020, v.21 no.1, 50
    SCIE Scopus dColl.
  • Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease Scientific Reports, 2020, v.10 no.1, 17491
    SCIE Scopus dColl.
  • 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma KOREAN JOURNAL OF RADIOLOGY, 2019, v.20 no.7, 1042-
    SCIE Scopus KCI dColl.
  • Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects PLOS ONE, 2019, v.14 no.3, e0213692
    SCIE Scopus dColl.
  • Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices JOURNAL OF HEPATOLOGY, 2019, v.70 no.3, 412-422
    SCIE Scopus dColl.
  • Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial JOURNAL OF HEPATOLOGY, 2019, v.70 no.4, 684-691
    SCIE Scopus dColl.
  • The Efficacy of Cone-Beam CT–Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization Journal of Vascular and Interventional Radiology, 2019, v.30 no.3, 358-369
    SCIE Scopus dColl.
  • Tumor marker-based definition of the transarterial chemoembolization-refractoriness in intermediate-stage hepatocellular carcinoma: A multi-cohort study Cancers, 2019, v.11 no.11, 1721
    SCIE Scopus dColl.
  • A Model for Adaptive Decision Making of 'Ablate-and-Wait' Versus Transplantation in Patients with Hepatocellular Carcinoma Journal of Clinical Gastroenterology, 2018, v.52 no.7, 655-661
    SCIE Scopus dColl.
  • Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality Scientific Reports, 2018, v.8 no.1, 13651
    SCIE Scopus dColl.
  • Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial TRIALS, 2018, v.19, 696
    SCIE Scopus dColl.
  • Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, v.47 no.11, 1490-1501
    SCIE Scopus dColl.
  • Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study BMC CANCER, 2018, v.18
    SCIE Scopus dColl.
  • Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study JOURNAL OF MEDICAL VIROLOGY, 2018, v.90 no.10, 1593-1603
    SCIE Scopus dColl.
  • Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib CANCER RESEARCH AND TREATMENT, 2018, v.50 no.2, 366-373
    SCIE Scopus KCI dColl.
  • Current immunotherapeutic strategies in hepatocellular carcinoma: Recent advances and future directions Therapeutic Advances in Gastroenterology, 2017, v.10 no.10, 805-814
    SCIE Scopus dColl.
  • Noninvasive prediction of hemodynamic response to carvedilol therapy for primary prophylaxis in cirrhotic patients with esophageal varices: a prospective study JOURNAL OF HEPATOLOGY, 2017, v.66 no.1, S47-S47
    SCIE Scopus dColl.
  • Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients PLOS ONE, 2017, v.12 no.1
    SCIE Scopus dColl.
  • 소라페닙 치료 실패 후 반복적인 경동맥 화학색전술로 장기 생존한 1예 대한간암학회지, 2017, v.17 no.1, 82~87
    KCI후보 dColl.
  • A Novel Biomarker-Based Model for the Prediction of Response to Sorafenib and Overall Survival for Advanced Hepatocellular Carcinoma: A Prospective Cohort Study HEPATOLOGY, 2016, v.63 no.1 SUPP, 634A-634A
    SCIE Scopus dColl.
  • Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome MEDICINE, 2016, v.95 no.2, e2454
    SCIE Scopus dColl.
  • Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, v.31 no.2, 427-433
    SCIE Scopus dColl.
  • Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, v.31 no.4, 814-821
    SCIE Scopus dColl.
  • Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! GUT AND LIVER, 2016, v.10 no.6, 869-870
    SCIE Scopus KCI dColl.
  • Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! Gut and Liver, 2016, v.10 no.6, 869
    SCIE Scopus KCI dColl.
  • Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria ANNALS OF SURGERY, 2016, v.263 no.5, 842-850
    SCIE Scopus dColl.
  • Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay GUT AND LIVER, 2015, v.9 no.5, 657-664
    SCIE Scopus KCI dColl.
  • Prospective Comparison of Noninvasive Fibrosis Assessment to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis C JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, v.49 no.8, 697-704
    SCIE Scopus dColl.
  • Reduction of Oxidative Stress Attenuates Lipoapoptosis Exacerbated by Hypoxia in Human Hepatocytes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, v.16 no.2, 3323-3334
    SCIE Scopus dColl.
  • The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients MEDICINE, 2015, v.94 no.24, e1031
    SCIE Scopus dColl.
  • Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease MEDICINE, 2015, v.94 no.48, e2159
    SCIE Scopus dColl.
  • MicroRNA-196A-2 Polymorphisms and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B JOURNAL OF MEDICAL VIROLOGY, 2014, v.86 no.3, 446-453
    SCIE Scopus dColl.
  • [학술지논문] Recent advances in nonalcoholic fatty liver disease metabolomics Clinical and molecular hepatology, 2021, v.27 no.4 , 553-559
    SCIE
  • [학술지논문] Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma Clinical and molecular hepatology, 2020, v.26 no.2 , 238-239
    SCIE
  • [학술지논문] Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease SCIENTIFIC REPORTS, 2020, v.10 no.1 , 17491-17491
    SCI
  • [학술지논문] Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study CANCERS, 2019, v.11 no.11 , 1721-1721
    SCIE
  • [학술지논문] Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality SCIENTIFIC REPORTS, 2018, v.8 no.13651 , 1-12
    SCI
  • [학술지논문] Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study JOURNAL OF MEDICAL VIROLOGY, 2018, v.90 no.10 , 1593-1603
    SCI
강의
  • 2021-2학기

    • 내과학실습Ⅳ

      • 학수번호 37644분반 01
      • 3학년 ( 4학점 , 220시간)
      • 전공필수 팀티칭, 의학과 외 수강불가, 자체시간표에 따른 운영
    • 의과학심화연구

      • 학수번호 38914분반 01
      • 1학년 ( 1학점 , 32시간)
      • 팀티칭, 의학과 외 수강불가, 해당 연구실, 자체시간표에 따른 운영
  • 2021-1학기

    • 소화기계

      • 학수번호 37615분반 01
      • 2학년 ( 3학점 , 69시간)
      • 전공필수 의학과 외 수강불가, 팀티칭, 자체시간표에 따라 운영
    • 내과학실습Ⅳ

      • 학수번호 37644분반 01
      • 3학년 ( 4학점 , 220시간)
      • 전공필수 의학과 외 수강불가, 팀티칭, 자체시간표에 따라 운영[일부 주차 대면수업]
  • 2020-2학기

    • 내과학실습Ⅳ

      • 학수번호 37644분반 01
      • 3학년 ( 4학점 , 220시간)
      • 전공필수 팀티칭, 의학과 외 수강불가, 자체시간표에 따른 운영, 전 기간 대면수업(강의계획안 참조, 조별 일정에 따름)
  • 2020-1학기

    • 소화기계

      • 학수번호 37615분반 01
      • 2학년 ( 3학점 , 69시간)
      • 전공필수 의학과 외 수강불가, 팀티칭, 자체시간표에 따라 운영
    • 내과학실습Ⅳ

      • 학수번호 37644분반 01
      • 3학년 ( 4학점 , 220시간)
      • 전공필수 의학과 외 수강불가, 팀티칭, 자체시간표에 따라 운영
  • 2019-2학기

    • 의과학개별연구

      • 학수번호 37500분반 02
      • 2학년 ( 2학점 , 2시간) 금 5~6 (의301)
      • 추가개설,타전공생수강불가,100분수업
    • 내과학실습Ⅳ

      • 학수번호 37644분반 01
      • 3학년 ( 4학점 , 220시간)
      • 전공필수 팀티칭, 의학과 외 수강불가, 자체시간표에 따른 운영
    • 내과학실습 IV

      • 학수번호 K10104분반 02
      • 학년 ( 4학점 , 220시간)
  • 2019-1학기

    • 소화기계

      • 학수번호 37615분반 01
      • 2학년 ( 3학점 , 69시간)
      • 전공필수 의학과 외 수강불가, 팀티칭, 자체시간표에 따라 운영
    • 내과학실습Ⅳ

      • 학수번호 37644분반 01
      • 3학년 ( 4학점 , 220시간)
      • 전공필수 의학과 외 수강불가, 자체시간표에 따라 운영
    • 내과학실습 IV

      • 학수번호 K10104분반 02
      • 학년 ( 4학점 , 220시간)
학력

서울대학교 의학박사(의학과)

서울대학교 의학석사(의학과)

서울대학교 의학사(의학과)